H Hatcher, R Planalp, J Cho, et al. Curcumin: From ancient medicine to current clinical trials[J]. Cell Mol Life Sci,2008,65(11):1631.
[2]
John R Cashman, Senait Ghirmai, Kenneth J Abel ,et al. Immune defects in Alzheimer\'s disease： new medications Development[J]. BMC Neurosci,2008,9（l2）：S1.
[3]
Bharat B Aggarwal, Kuzhuvelil B, Harikumar. Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases[J]. Int J Biochem Cell Biol,2009,41(1)：40.
[4]
Aynun N Begum, Mychica R Jones, Giselle P Lim, et al. Curcumin Structure-Function, Bioavailability, and Efficacy in Models of Neuroinflammation and Alzheimer\'s Disease[J]. J Pharmacol Exp Ther,2008,326（1）：196.
[5]
Giselle P Lim, Teresa Chu, Fusheng Yang, et al. The Curry Spice Curcumin Reduces Oxidative Damage and Amyloid Pathology in an Alzheimer Transgenic Mouse[J]. J Neurosci,2001,21(21)：8370.
[6]
Philip Thomasa,Yan-Jiang Wang,Jin-Hua Zhong, et al. Grape seed polyphenols and curcumin reduce genomic instability events in a transgenic mouse model for Alzheimer\'s disease[J]. Mutat Res,2009,661(1/2)：25.
[7]
Syuan Sung,Yuemang Yao,Kunihiro Uryu, et al. Early Vitamin E upplementation in young but not aged mice reduces Aβ levels and amyloid deposition in a transgenic model of Alzheimer’s disease[J]. FASEB J,2004,18(2)：323.
[8]
Domenico Pratico,Christopher M. Clark,Feyan Liun, et al. Increase of Brain Oxidative Stress in Mild Cognitive ImpairmentA Possible Predictor of Alzheimer Disease[J]. Arch Neurol,2002,59(6)：972.
[9]
H Hatcher,R Planalp,J Chob, et al. Curcumin: From ancient medicine to current clinical trials[J]. Cell Mol Life Sci,2008,65(11):1631.
[10]
John M Ringman,Sally A Frautschy,Gregory M Cole, et al. A Potential Role of the Curry Spice Curcumin in Alzheimer\'s Disease[J]. Curr Alzheimer Res,2005,2（2）：131.
[11]
S Salvioli,E Sikora,E L Cooper, et al. Curcumin in Cell Death Processes：A Challenge for CAM ofAge-RelatedPathologies[J]. eCAM,2007,4(2)：181.
[12]
Suh H W,Kang S,Kwon K S. Curcumin attenuates glutamate-induced HT22 cell death by suppressing MAP kinase signaling [J]Mol Cell Biochem, 2007,298(1/2):187.
[13]
Lee H S,Jung K K,Cho J Y, et al. Neuroprotective effect of curcumin is mainly mediated by blockade of microglial cell activation[J].Pharmazie,2007,62(12):937.
[14]
Jiang J,Wang W,Sun YJ, et al. Neuroprotective effect of curcumin on focal cerebral ischemic rats by preventing blood-brain barrier damage[J]. Eur J Pharmacol, 2007,561(1/3):54.
[15]
Pan Rui,Qiu Sheng,LU Da-xiang , et al. Curcumin improves learning and memory ability and its neuroprotective mechanism in mice[J]. Chin Med J,2008,121(9)：832.
[16]
Santosh K Sandur,Manoj K Pandey,Bokyung Sung, et al. Curcumin, demethoxycurcumin, bisdemethoxycurcumin, tetrahydrocurcumin and turmerones differentially regulate anti-inflammatory and anti-proliferative responses through a ROS-independent mechanism[J]. Carcinogenesis,2007,28(8)：1765.
[17]
Padmini Srinivasan1, Bisharah Libbus.Mining Medline for implicit links between dietary substances and diseases[J]. Bioinformatics,2004,20(1)：290.
[18]
Maria M LoTempio,Mysore S Veena, Helen L Steele, et al. Curcumin Suppresses Growth of Head and Neck Squamous Cell Carcinoma[J]. Cancer Res,2005,11(19)：6994.
[19]
Bharat B Aggarwal,Kuzhuvelil B Harikumar. Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary,metabolic,autoimmune and neoplastic diseases[J]. Int J Biochem Cell Biol,2009,41(1)：40.
[20]
Philip Thomas,Michael Fenech. A review of genome mutation and Alzheimer\'s disease[J]. Mutagenesis,2007,22(1)：15.
[21]
M Garcia-Alloza,L A Borrelli,A Rozkalne, et al. Curcumin labels amyloid pathology in vivo, disrupts existing plaques, and partially restores distorted neurites in an Alzheimer mouse model[J]. J Neurochem, 2007,102(4)：1095.
[22]
Fusheng Yang, Giselle P Lim, Aynun N Begum, et al. Curcumin Inhibits Formation of Amyloid β Oligomers and Fibrils,Binds Plaques,and Reduces Amyloid in Vivo[J]. J Biol Chem,2005,280(7)：5892.
[23]
Raozhou Lin,Xiaohong Chen,Wenming Li, et al. Exposure to metal ions regulates mRNA levels of APP and BACE1 in PC12 cells： Blockage by curcumin[J]. Neurosci Lett,2008,440(3)：344.
[24]
Marco Racchi,Daniela Uberti,Stefano Govoni, et al. Alzheimer\'s disease： new diagnostic and therapeutic tools[J]. Immunity & Ageing,2008,5：7.
[25]
Sun-Oh Jeong,Gi-Su Oh,Hun-Yong Ha, et al. Demethoxycurcumin, a synthetic Curcumin Analogue, Induces Heme Oxygenase-1 Expression through Nrf2 Activation in RAW264.7 Macrophages[J]. J Clin Biochem,2009,44(1)：79.
[26]
Hani Atamna, Kathleen Boyle. Amyloid-β peptide binds with heme to form a peroxidase：Relationship to the cytopathologies of Alzheimer’s disease[J]. Pnas, 2006,103(9)：3381.
[27]
So-Young Park, Hyo-Shin Kim, Eun-Kyung Cho, et al. Curcumin protected PC12 cells against beta-amyloid-induced toxicity through the inhibition of oxidative damage and tau hyperphosphorylation[J]. Food Chem Toxic, 2008, 46(8)：2881.
[28]
Zhao J,Zhao Y,Zheng W,Lu Y, et al. Neuroprotective effect of curcumin on transient focal cerebral ischemia in rats[J]. Brain Res, 2008,1229：224.
[29]
M P Lambert, A K Barlow, B A Chromy, et al.Diffusible, nonfibrillar ligands derived from Aβ1–42 are potent central nervous system neurotoxins[J]. Proc Natl Acad Sci USA,1998,95(11)：6448.
[30]
Wei-Qin Zhao, Fernanda G. De Felice, Sara Fernandez, et al. Amyloid beta oligomers induce impairment of neuronal insulin receptors[J]. Faseb J, 2008,22(1)：246.
[31]
Oleg Butovsky, Maya Koronyo-Hamaoui, Gilad Kunis, et al. Glatiramer acetate fights against Alzheimer\'s disease by inducing dendritic-like microglia expressing insulin-like growth factor 1[J]. Pnas,2006,103(31)：11784.
[32]
Fernanda G De Felice, Marcelo N N Vieira, Theresa R Bomfim, et al. Protection of synapses against Alzheimer’s-linked toxins： Insulin signaling prevents the pathogenic binding of Aβ oligomers [J]. Pnas, 2009,106(6)：1971.
[33]
Ahmet Turan Isik, Turgay Celik, Gokhan Ulusoy, et al. Curcumin ameliorates impaired insulin/IGF signalling and memory deficit in a streptozotocin-treated rat model[J]. AGE,2009,31(1)：39.
[34]
Thor D. Stein, Jeffrey A. Johnson. Lack of Neurodegeneration in Transgenic Mice Overexpressing Mutant Amyloid Precursor Protein Is Associated with Increased Levels of Transthyretin and the Activation of Cell Survival Pathways[J]. J Neurosci, 2002, 22(17)：7380.
[35]
Yu Y, Hu SK, Yan H. The study of insulin resistance and leptin resistance on the model of simplicity obesity rats by curcumin[J]. ×××××××（中华预防医学杂志）,2008,42(11)：818.
